
Facebook on Monday filed a motion to dismiss the Federal Trade Commission’s amended antitrust complaint against the social network, reported The New York Times.
The amended complaint, filed in August, is focused on the social media giant’s acquisitions of Instagram and WhatsApp, accusing Facebook of unlawfully maintaining its dominance by acquiring or eliminating companies it sees as competitive threats.
In June, US District Judge James Boasberg dismissed an earlier antitrust complaint filed by the FTC, saying the agency hadn’t provided enough evidence that Facebook has monopoly power in personal social networking.
Facebook on Monday said the amended complaint should “suffer the same fate,” arguing that the FTC can’t credibly claim the social network has monopoly power.
“The FTC’s fictional market ignores the competitive reality: Facebook competes vigorously with TikTok, iMessage, Twitter, Snapchat, LinkedIn, YouTube, and countless others to help people share, connect, communicate or simply be entertained,” said a Facebook spokesperson in an emailed statement. “We continuously innovate and improve our products and services to earn people’s time and attention because we have to.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas